Does long-term metformin treatment increase cardiac lipoprotein lipase?
Author:
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in Metabolism
- Vol. 60 (1) , 32-42
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation (06/007)
This publication has 53 references indexed in Scilit:
- Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart FailureCirculation Research, 2009
- Metabolic Switch and Hypertrophy of Cardiomyocytes following Treatment with Angiotensin II Are Prevented by AMP-activated Protein KinaseJournal of Biological Chemistry, 2008
- Cold acclimation induces physiological cardiac hypertrophy and increases assimilation of triacylglycerol metabolism through lipoprotein lipaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Metabolic actions of metformin in the heart can occur by AMPK-independent mechanismsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated SignalingDiabetes, 2008
- Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscleBiochemical and Biophysical Research Communications, 2007
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Metformin—An updateGeneral Pharmacology: The Vascular System, 1993
- Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese zucker ratsLife Sciences, 1992